Applying advanced technologies to improve clinical trials: a systematic mapping study

Esther Nanzayi Ngayua, Jianjia He () and Kwabena Agyei-Boahene
Additional contact information
Esther Nanzayi Ngayua: University of Shanghai for Science and Technology
Jianjia He: University of Shanghai for Science and Technology
Kwabena Agyei-Boahene: Tongji University

Scientometrics, 2021, vol. 126, issue 2, No 15, 1217-1238

Abstract: Abstract The increasing demand for new therapies and other clinical interventions has made researchers conduct many clinical trials. The high level of evidence generated by clinical trials makes them the main approach to evaluating new clinical interventions. The increasing amounts of data to be considered in the planning and conducting of clinical trials has led to higher costs and increased timelines of clinical trials, with low productivity. Advanced technologies including artificial intelligence, machine learning, deep learning, and the internet of things offer an opportunity to improve the efficiency and productivity of clinical trials at various stages. Although researchers have done some tangible work regarding the application of advanced technologies in clinical trials, the studies are yet to be mapped to give a general picture of the current state of research. This systematic mapping study was conducted to identify and analyze studies published on the role of advanced technologies in clinical trials. A search restricted to the period between 2010 and 2020 yielded a total of 443 articles. The analysis revealed a trend of increasing research interests in the area over the years. Recruitment and eligibility aspects were the main focus of the studies. The main research types were validation and evaluation studies. Most studies contributed methods and theories, hence there exists a gap for architecture, process, and metric contributions. In the future, more empirical studies are expected given the increasing interest to implement the AI, ML, DL, and IoT in clinical trials.

Keywords: Artificial intelligence; Machine learning; Deep learning; Internet of things; Clinical trials (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s11192-020-03774-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:scient:v:126:y:2021:i:2:d:10.1007_s11192-020-03774-1

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/11192

DOI: 10.1007/s11192-020-03774-1

Access Statistics for this article

Scientometrics is currently edited by Wolfgang Glänzel

More articles in Scientometrics from Springer, Akadémiai Kiadó
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().